* Cardlytics Inc CDLX.OQ CDLX.O is expected to show a
rise in
quarterly revenue when it reports results on May 2.
* The Atlanta Georgia-based company is expected to report
a
21.5% increase in revenue to $64.66 million from $53.23 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 55 cents per share. For the same quarter last year, the
company reported a loss of 34 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$72, above its last closing price of $34.13.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.36 -0.42 -0.15 Beat 63.9
Sep. 30 2021 -0.52 -0.54 -0.33 Beat 38.9
Jun. 30 2021 -0.38 -0.39 -0.39 Met -0.9
Mar. 31 2021 -0.44 -0.34 -0.34 Met -0.6
Dec. -0.04 -0.03 -0.05 Missed -92.3
31 2020
Sep. 30 2020 -0.28 -0.28 -0.16 Beat 42.9
Jun. 30 2020 -0.45 -0.47 -0.38 Beat 19.8
Mar. 31 2020 -0.22 -0.21 -0.26 Missed -21.9
This summary was machine generated April 30 at 02:06 GMT. All
figures in US dollars unless otherwise stated